clinical trial · NCT04838171
Prospective Study of White Blood Cells
Quell Therapeutics Limited·—·recruiting·n = 10
Autoimmune DiseasesInflammationRejection; Transplant, LiverWhite blood cell and blood collection
brief summary
The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies.
started
Mar 24, 2021
primary completion
Dec 31, 2029
completion
Jan 1, 2030
last updated
Jan 21, 2026
official title
Investigation of White Blood Cells to Support the Development of Engineered Regulatory T Cell (Treg) Therapies
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol